| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 6.26B | — |
| Operating expense | — | — |
| Net income | 870.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DHR returned +4.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -4.0% |
| 1 year | +4.1% |
| 5 years | -22.0% |
| 10 years | +219.1% |
| All-time high | $291.68 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in DHR would be worth today ›Yes. Danaher Corporation paid 4 dividends over the past 12 months. The most recent was $0.40 per share on Jun 26, 2026. The dividend yield is 0.73%.
Danaher Corporation stock trades on NYSE under the ticker symbol DHR.
Danaher Corporation is part of the Healthcare sector.
Danaher Corporation has a market cap of 153.85B USD, based on the latest quote.
Danaher Corporation is expected to report earnings around Oct 20, 2026. That date is an estimate and has not been confirmed by the company.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
